CERT Certara, Inc.
Certara, Inc. (CERT) is expected to report earnings on November 9, 2026, before the market open. The consensus earnings estimate is $0.06 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +43.9% since its last earnings release on August 4, 2026.
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About Certara, Inc.
Certara accelerates medicines using biosimulation software and technology to transform traditional drug discovery and development.
Sector
Healthcare
Industry
Research Services
Charts powered in part by Lightweight Charts™ by TradingView.